Benzinga's Top Upgrades

By: via Benzinga
Analysts at Bank of America upgraded Seattle Genetics (NASDAQ: SGEN) from “underperform” to “neutral.” The target price for Seattle ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.